Dec 4, 2024 | Legal Compliance
The weight-loss medication market has been experiencing seismic shifts, with pharmaceutical giants Eli Lilly and Novo Nordisk leading the charge. Recent clinical trial results have added more heat to this competition: Lilly’s Zepbound outperformed Novo’s Wegovy in a...
Dec 4, 2024 | Legal Compliance
Semaglutide, the active ingredient in blockbuster drugs Ozempic and Wegovy, is poised to reshape the pharmaceutical and wellness industries as its molecule patent approaches expiration in 2025. While this development is exciting, utility and formulation patents...
Nov 8, 2024 | Legal Compliance, Risk Management
In today’s healthcare industry, rising medication costs and global access to treatment options have led many patients to explore importing medications for personal use or bringing necessary prescriptions when traveling internationally. However, understanding the U.S....
Nov 8, 2024 | Legal Compliance
With the 2024 presidential election behind us and Donald Trump securing his second term, healthcare businesses now face the prospect of significant policy shifts. Given his past healthcare initiatives and campaign promises, Trump’s administration is expected to drive...
Nov 4, 2024 | Legal Compliance
When running a business, keeping up with regulatory compliance is essential—not just to protect your business reputation but to avoid hefty fines and potential legal consequences. One such critical compliance obligation is the Beneficial Ownership Information...
Jan 31, 2024 | Finance & Tax Planning, Legal Compliance
As healthcare attorneys, our job is to deftly guide you through the intertwining web of state and federal healthcare laws to help you run a compliant healthcare practice or business. Many of these laws are vague on their face. Courts and regulators’ conflicting and...
